The short answer is YES. Paxlovid remains an important treatment option for people at high risk for bad outcomes from COVID-19 infection, specifically people over age 50. If you have COVID-19 and are at high risk for complications, Paxlovid is definitely worth discussing with a clinician. While the original Paxlovid clinical trials were conducted in Read more…